Emphysema - Pipeline Review, H1 2016 Summary Global Markets Direct's, ‘Emphysema - Pipeline Review, H1 2016', provides an overview of the Emphysema pipeline landscape. The report provides comprehensive information on the therapeutics under development for Emphysema, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Emphysema and features dormant and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data. Scope - The report provides a snapshot of the global therapeutic landscape of Emphysema - The report reviews pipeline therapeutics for Emphysema by companies and universities/research institutes based on information derived from company and industry-specific sources - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved Emphysema therapeutics and enlists all their major and minor projects - The report assesses Emphysema therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report summarizes all the dormant and discontinued pipeline projects - The report reviews latest news related to pipeline therapeutics for Emphysema Reasons to Buy - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for Emphysema - Identify potential new clients or partners in the target demographic - Develop strategic initiatives by understanding the focus areas of leading companies - Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding Emphysema pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Table of Content
Table of Contents 2 List of Tables 4 List of Figures 4 Introduction 5 Global Markets Direct Report Coverage 5 Emphysema Overview 6 Therapeutics Development 7 Pipeline Products for Emphysema - Overview 7 Pipeline Products for Emphysema - Comparative Analysis 8 Emphysema - Therapeutics under Development by Companies 9 Emphysema - Therapeutics under Investigation by Universities/Institutes 10 Emphysema - Pipeline Products Glance 11 Clinical Stage Products 11 Early Stage Products 12 Emphysema - Products under Development by Companies 13 Emphysema - Products under Investigation by Universities/Institutes 14 Emphysema - Companies Involved in Therapeutics Development 15 Abeona Therapeutics, Inc. 15 Angion Biomedica Corp. 16 ProMetic Life Sciences Inc. 17 rEVO Biologics, Inc. 18 Emphysema - Therapeutics Assessment 19 Assessment by Monotherapy Products 19 Assessment by Target 20 Assessment by Mechanism of Action 22 Assessment by Route of Administration 24 Assessment by Molecule Type 26 Drug Profiles 28 alpha-1 proteinase inhibitor (human) - Drug Profile 28 Product Description 28 Mechanism of Action 28 R&D Progress 28 alpha-1 proteinase inhibitor (human) - Drug Profile 29 Product Description 29 Mechanism of Action 29 R&D Progress 29 BB-3 - Drug Profile 30 Product Description 30 Mechanism of Action 30 R&D Progress 30 EDO-66 - Drug Profile 34 Product Description 34 Mechanism of Action 34 R&D Progress 34 MG-53 - Drug Profile 35 Product Description 35 Mechanism of Action 35 R&D Progress 35 Monoclonal Antibody to Inhibit EMAP II for Emphysema - Drug Profile 37 Product Description 37 Mechanism of Action 37 R&D Progress 37 Recombinant Human Alpha-1 Antitrypsin - Drug Profile 38 Product Description 38 Mechanism of Action 38 R&D Progress 38 TM-5441 - Drug Profile 39 Product Description 39 Mechanism of Action 39 R&D Progress 39 Emphysema - Recent Pipeline Updates 41 Emphysema - Dormant Projects 42 Appendix 43 Methodology 43 Coverage 43 Secondary Research 43 Primary Research 43 Expert Panel Validation 43 Contact Us 43 Disclaimer 44
List of Tables
Number of Products under Development for Emphysema, H1 2016 7 Number of Products under Development for Emphysema - Comparative Analysis, H1 2016 8 Number of Products under Development by Companies, H1 2016 9 Number of Products under Investigation by Universities/Institutes, H1 2016 10 Comparative Analysis by Clinical Stage Development, H1 2016 11 Comparative Analysis by Early Stage Development, H1 2016 12 Products under Development by Companies, H1 2016 13 Products under Investigation by Universities/Institutes, H1 2016 14 Emphysema - Pipeline by Abeona Therapeutics, Inc. , H1 2016 15 Emphysema - Pipeline by Angion Biomedica Corp., H1 2016 16 Emphysema - Pipeline by ProMetic Life Sciences Inc., H1 2016 17 Emphysema - Pipeline by rEVO Biologics, Inc., H1 2016 18 Assessment by Monotherapy Products, H1 2016 19 Number of Products by Stage and Target, H1 2016 21 Number of Products by Stage and Mechanism of Action, H1 2016 23 Number of Products by Stage and Route of Administration, H1 2016 25 Number of Products by Stage and Molecule Type, H1 2016 27 Emphysema Therapeutics - Recent Pipeline Updates, H1 2016 41 Emphysema - Dormant Projects, H1 2016 42
List of Figures
Number of Products under Development for Emphysema, H1 2016 7 Number of Products under Development for Emphysema - Comparative Analysis, H1 2016 8 Number of Products under Development by Companies, H1 2016 9 Comparative Analysis by Early Stage Products, H1 2016 12 Assessment by Monotherapy Products, H1 2016 19 Number of Products by Targets, H1 2016 20 Number of Products by Stage and Targets, H1 2016 20 Number of Products by Mechanism of Actions, H1 2016 22 Number of Products by Stage and Mechanism of Actions, H1 2016 22 Number of Products by Routes of Administration, H1 2016 24 Number of Products by Stage and Routes of Administration, H1 2016 24 Number of Products by Molecule Types, H1 2016 26 Number of Products by Stage and Molecule Types, H1 2016 26
Global intelligent transportation system (ITS) market is estimated to attain USD 38.68 billion by 2020, as per a new research report by Radiant Insights, Inc. Cost effectiveness along with escalating need for road safety is likely to boost global demRead More...
Global animal feed additives market size was estimated at USD 16 billion in 2014. Growing meat consumption as a key protein source, especially in Asia Pacific and Latin America is expected to be a key driver for market demand over the forecast periodRead More...
Global PP (Polypropylene) nonwoven fabric market size is anticipated to be valued at USD 30.6 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing usage of hygiene products such as incontinence products and baby diapers isRead More...
Global alpha olefins market size is likely to be valued at USD 10.7 billion by 2020; as per a new research report by Radiant Insights, Inc. Increasing polyethylene demand for use in plastic production is anticipated to drive market growth. Growing apRead More...
Global thermoplastic polyurethane (TPU) films market size is likely to be valued at USD 724.6 million by 2020; as per a new research report by Radiant Insights, Inc. Increase in lightweight plastics demand in order to achieve vehicle fuel efficiencyRead More...
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.